These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26182826)

  • 21. Advanced HIV Disease at Antiretroviral Therapy Initiation and Treatment Outcomes Among Children and Adolescents Compared to Adults Living With HIV in Kinshasa, Democratic Republic of the Congo.
    Chabikuli ON; Ditekemena JD; Sigwadhi LN; Mulenga A; Mboyo A; Bidashimwa D; Nachega JB
    J Int Assoc Provid AIDS Care; 2023; 22():23259582231221955. PubMed ID: 38146172
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ocular manifestations of children living with HIV/AIDS in Kinshasa].
    Nsiangani NL; Kaimbo Wa Kaimbo D; Kapepela MK
    Bull Soc Belge Ophtalmol; 2013; (322):117-24. PubMed ID: 24923092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synchronous kinetics of CD4+ lymphocytes and viral load before the onset of oral candidosis and hairy leukoplakia in a cohort of Mexican HIV-infected patients.
    Ramírez-Amador V; Ponce-De-León S; Sierra-Madero J; Soto-Ramírez L; Esquivel-Pedraza L; Anaya-Saavedra G
    AIDS Res Hum Retroviruses; 2005 Dec; 21(12):981-90. PubMed ID: 16379600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
    Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
    J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
    AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility.
    Callens SF; Kitetele F; Lusiama J; Shabani N; Edidi S; Colebunders R; Behets F; Van Rie A
    BMC Infect Dis; 2008 Mar; 8():31. PubMed ID: 18325119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological, clinical and biological profile of neuromeningeal cryptococcosis among people living with HIV in Kinshasa, Democratic Republic of Congo.
    Zono B; Kamangu E; Situakibanza H; Amaela E; Bepouka B; Mbula M; Kayembe JM; Mvumbi G; Hayette MP
    Pan Afr Med J; 2020; 37():302. PubMed ID: 33654521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians.
    Mekonnen Y; Dukers NH; Sanders E; Dorigo W; Wolday D; Schaap A; Geskus RB; Coutinho RA; Fontanet A
    AIDS; 2003 Apr; 17(6):815-9. PubMed ID: 12660528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
    Shah I; Parikh S
    J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.
    Revankar SG; Sanche SE; Dib OP; Caceres M; Patterson TF
    AIDS; 1998 Dec; 12(18):2511-3. PubMed ID: 9875598
    [No Abstract]   [Full Text] [Related]  

  • 31. Gender differences in human immunodeficiency virus-related oral lesions: an Italian study.
    Campisi G; Pizzo G; Mancuso S; Margiotta V
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):546-51. PubMed ID: 11346733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative and evolutionary profile of people infected with HIV on antiretroviral therapy in Kinshasa, Democratic Republic of Congo].
    Koy T; Mukumbi H; Malandala GL; Donnen P; Wilmet-Dramaix M
    Pan Afr Med J; 2014; 19():388. PubMed ID: 25995784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds.
    Palacios GC; Sanchez LM; Briones E; Ramirez TJ; Castillo H; Rivera LG; Vazquez CA; Rodriguez-Padilla C; Holodniy M
    Int J Infect Dis; 2010 Jan; 14(1):e34-40. PubMed ID: 19467895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy.
    Navarro J; Resino S; Bellón JM; Abad ML; Gurbindo D; Fernández-Cruz E; Muñóz-Fernández MA
    AIDS Res Hum Retroviruses; 2001 Apr; 17(6):525-32. PubMed ID: 11350666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India.
    Ghate MV; Mehendale SM; Mahajan BA; Yadav R; Brahme RG; Divekar AD; Paranjape RS
    Natl Med J India; 2000; 13(4):183-7. PubMed ID: 11002684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART.
    Gaitán-Cepeda LA; Martínez-González M; Ceballos-Salobreña A
    AIDS Patient Care STDS; 2005 Feb; 19(2):70-7. PubMed ID: 15716638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
    Yang YL; Lo HJ; Hung CC; Li Y
    BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.